Click here for slides on this topic


Orlistat

Agent used to treat obesity.
The following content matched the glossary term: Orlistat

ADA/European Association for the Study of Diabetes (EASD) Position Statement on Hyperglycemia Management in Type 2 Diabetes

Top

Joint position statement from ADA/EASD with clinical practice recommendations for managing hyperglycemia in type 2 diabetes

Long-term effects of weight-reducing interventions in hypertensive patients: systemic review and meta-analysis

Top

Horvath K, Jeitler K, Siering U, et al. Long-term effects of weight-reducing interventions in hypertensive patients: systematic review and meta-analysis. Arch Intern Med. 2008;168(6):571-580. Weight loss is recommended in all major guidelines for antihypertensive therapy. We searched for randomized controlled trials investigating the effects of weight-reducing diets, pharmacologic substances, and invasive interventions for weight reduction on patient-relevant end points and blood pressure (BP) in patients with essential hypertension.

Pharmacologic prevention or delay of type 2 diabetes mellitus

Top

Anderson DC, Jr. Pharmacologic prevention or delay of type 2 diabetes mellitus. Ann Pharmacother. 2005;39:102-109. To evaluate the current data on pharmacologic interventions intended to prevent or delay the onset of type 2 diabetes mellitus.

Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis

Top

Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Kim C, Lau J. Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med. 2004;164:1395-1404. Obesity is closely related to type 2 diabetes mellitus, and weight reduction is an important part of the care delivered to obese persons with diabetes. The objective of this review was to assess the efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes.



Slide Library Results

Search Results for: Orlistat Slides Found: 9
Agents That Alter Metabolism
Effect of Orlistat on Weight Loss in Patients With Type 2 Diabetes
Effect of Orlistat on Weight Loss in Patients With Type 2 Diabetes
Effect of Orlistat on the Prevention of Type 2 Diabetes: XENDOS
Effect of Orlistat on Lipids and Glycemic Control in Patients
Effect of Sibutramine, Orlistat, and Metformin on Risk Factors for Type 2 Diabetes
Effect of Sibutramine Plus Orlistat
Long-Term Obesity Medications: At Least 5% Weight Loss After 1 Year
AHA/ACC/TOS Obesity Guidelines: Weight Loss Outcomes in Overweight or Obese Adults